Join our cancer enterprise at Cedars-Sinai Cancer during a transformational period of growth and help us achieve our goal of becoming a top tier nationally recognized Cancer Center. Ranked by US News & World Report as the #7 Best Hospital in Cancer in 2020-2021, Cedars-Sinai Cancer is seeking an accomplished academic liver oncology leader for the position of Director, Liver Cancer Research
Are you a scientist leader ready to drive the liver cancer research efforts of the Cedars-Sinai Cancer during an exciting period of growth? Join us and together we will establish a first-rate multidisciplinary Liver Cancer Program. An endowed chair will be provided to the holder of this position.
Are you right for this role? We are looking for a leader who has a:
• proven track record of peer-reviewed liver cancer relevant extramural funding,
• extensive publication record in high impact peer-reviewed journals,
• successful track record of developing innovative research programs, and
• successful leadership experience in division, program or institute (of an NCI Designated Cancer Center)
Interested candidates should send their CV, a cover letter as well as names of three references to Dr. Dan Theodorescu c/o AcademicRecruiting@cshs.org
Cedars-Sinai seeks to find, develop and retain the best clinical and research faculty. We promote excellence through diversity and encourage all qualified applicants to apply. We are an equal opportunity/affirmative action employer, M/F/Vets/Disabled
The Director of Liver Cancer Research will partner with the Surgical and Medical Directors of Liver Cancer and lead the Liver Cancer Program collaboratively. The Director will establish first-rate multidisciplinary Liver Cancer Research and lead the development of research and educational programs by working collaboratively and bringing together researchers across the Cedars Sinai Health System.
The Director will develop and lead a comprehensive translational research program to study the pathophysiology of and to prevent, detect or treat primary and metastatic liver cancers. Of note is our specific interest in Asian and Hispanic populations in our catchment area and their higher rates of liver cancer. The Director must create a scientific culture and environment that promote the submission of research grants by Liver Cancer Program members and participate with the Cedars-Sinai Cancer Director in securing philanthropic support for the program. The Director will also be responsible for identifying, promoting and mentoring young investigators in liver cancer research.
In this role, you will:
• Develop a vision for a comprehensive research program to conduct basic, prevention, and translational research in liver cancer.
• Promote the success for obtaining external support through NIH, foundations, biotech/pharma and other extramural agencies for research.
• Work with the Directors of Cedars-Sinai Cancer and of the Karsh Division of Gastroenterology and Hepatology and other stakeholders as needed to recruit faculty focused on basic, prevention and translational liver cancer research.
• Advise and foster participation by interested and qualified trainees in relevant research areas.
• Identify and promote the mentoring of young investigators in liver cancer research.
• Train research fellows and laboratory staff in both translational and basic sciences in liver cancer.
• Develop and/or contribute to the development of training programs in liver cancer related sciences with institutional educational leaders.
• Establish a leadership team composed of the Liver Cancer Research Director, leaders in Hepatology, Medical Oncology, Hepatobiliary-Surgical Oncology and Radiation Oncology.
• Work with the Medical and Surgical Directors of the Liver Cancer Program to organize, implement and direct fiscally responsible research and educational programs in liver cancer.
• Work with the Director of Cedars-Sinai Cancer in securing philanthropic support for the program and marketing the program throughout the loco-regional and national/international communities.
• Ten or more years’ experience in liver diseases research (basic, prevention or translational)
• PhD, MD, MD/PhD or equivalent from an accredited university.
• For MD and MD/PhD, Board Certification in Internal Medicine, Gastroenterology, Hematology/Oncology, Radiation Oncology or Pathology by the corresponding American Board or the equivalent. Ability to obtain an unrestricted California medical license as Physician.
• National or international prominence in liver cancer research, with outstanding peer-reviewed publications, proven abilities as Principal Investigator and mentor.
• Demonstrated ability to obtain and sustain federal funding (NIH, NSF, DOD, etc.)
About Cedars-Sinai Cancer
Ranked by US News & World Report as the #7 Best Hospital in Cancer Nationally and #1 in California and West of Houston in 2020-2021, the Cedars-Sinai Cancer program sees over 4800 new cases of cancer per year and is part of the Cedars-Sinai Health System, a rapidly expanding vertically integrated health system with practices located in Southern California, including Tower Hematology- Oncology, The Angeles Clinic and Research Institute, Cedars-Sinai Valley Oncology Medical Group, Cedars-Sinai Marina del Rey hospital, Hunt Cancer Institute at Torrance Memorial, and Cedars-Sinai Medical Center.
Cedars-Sinai Cancer continues to pursue excellence with plans to greatly expand and sharpen the focus of its basic and translational research programs and its studies of populations and cancer disparities that are unique to its geographic area, focusing on cancer prevention and helping to change behaviors to ensure a healthier lifestyle.
About the Karsh Division of Gastroenterology and Hepatology
Ranked by US News & World Report as the #2 Best Hospital Nationally in Gastroenterology and GI Surgery in 2020-2021, the Karsh Division of Gastroenterology and Hepatology recently received a $25 million gift from Martha L. Karsh and Bruce A. Karsh, and the Karsh Family Foundation, to support the treatment of digestive and liver diseases and the advancement of innovative research. This transformative gift will allow the division to build on its national reputation for advancing the frontiers of science and medicine in digestive and liver diseases and establish the division as a leading research powerhouse.
Along with caring for patients, Cedars-Sinai is a hub for biomedical research and a top 10 academic medical center for NIH funding with over $200M in extramural research grant funding. As the largest academic medical center in the western United States, Cedars-Sinai is also training the next generation of physicians, researchers, and allied health professionals. Physicians and scientists at Cedars-Sinai are actively engaged in translational research to bring medical advancements directly from the laboratory to the bedside.
A commitment to meeting the community's health needs has been a defining quality of Cedars-Sinai since the beginning - from the opening of the 12-bed Kaspare Cohn Hospital in Angeleno Heights in 1902 to what is now a world-renowned, nonprofit academic medical center with 890 licensed beds.
Ranked by US News & World Report as the #7 Best Hospital in 2020-2021, Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow's health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.